66.03
price down icon0.50%   -0.33
after-market 시간 외 거래: 66.26 0.23 +0.35%
loading
전일 마감가:
$66.36
열려 있는:
$66.77
하루 거래량:
3.70M
Relative Volume:
0.81
시가총액:
$25.89B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
46.22
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
-1.87%
1개월 성능:
-17.99%
6개월 성능:
+7.14%
1년 성능:
-3.77%
1일 변동 폭
Value
$65.88
$67.43
1주일 범위
Value
$63.53
$68.00
52주 변동 폭
Value
$57.52
$93.25

덱스컴 Stock (DXCM) Company Profile

Name
명칭
Dexcom Inc
Name
전화
(858) 200-0200
Name
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
직원
10,300
Name
트위터
@dexcom
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
DXCM's Discussions on Twitter

DXCM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
DXCM
Dexcom Inc
66.03 26.02B 4.30B 571.50M 570.80M 1.4285
Medical Devices icon
ABT
Abbott Laboratories
133.02 232.77B 43.11B 13.94B 6.78B 7.9963
Medical Devices icon
BSX
Boston Scientific Corp
95.90 143.29B 18.49B 2.50B 3.49B 1.6801
Medical Devices icon
SYK
Stryker Corp
369.24 140.03B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
98.33 126.25B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
76.72 44.95B 5.69B 1.41B 577.90M 6.9828

덱스컴 Stock (DXCM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-08 다운그레이드 Oppenheimer Outperform → Perform
2025-08-21 개시 Argus Buy
2025-06-16 개시 Truist Buy
2025-05-30 개시 Goldman Buy
2025-04-10 개시 Mizuho Outperform
2025-02-03 업그레이드 Redburn Atlantic Neutral → Buy
2025-01-16 업그레이드 Robert W. Baird Neutral → Outperform
2024-07-26 다운그레이드 JP Morgan Overweight → Neutral
2024-07-26 다운그레이드 Robert W. Baird Outperform → Neutral
2024-05-30 개시 Redburn Atlantic Neutral
2024-03-12 개시 RBC Capital Mkts Outperform
2023-05-30 재개 Morgan Stanley Equal-Weight
2023-04-17 업그레이드 Raymond James Outperform → Strong Buy
2023-03-29 개시 UBS Buy
2023-01-26 개시 Wolfe Research Outperform
2022-10-18 개시 Barclays Equal Weight
2022-10-12 개시 Jefferies Buy
2022-07-15 개시 Bernstein Outperform
2022-03-02 재개 BofA Securities Buy
2022-02-03 업그레이드 BTIG Research Neutral → Buy
2022-01-19 업그레이드 Wells Fargo Equal Weight → Overweight
2022-01-07 업그레이드 Guggenheim Neutral → Buy
2021-10-18 다운그레이드 Guggenheim Buy → Neutral
2021-07-21 재개 Cowen Outperform
2021-05-28 업그레이드 Wells Fargo Underweight → Equal Weight
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Overweight
2021-01-06 업그레이드 UBS Neutral → Buy
2020-10-02 다운그레이드 Wells Fargo Equal Weight → Underweight
2020-05-27 재확인 Piper Sandler Overweight
2020-05-14 개시 Wells Fargo Equal Weight
2020-03-05 개시 Citigroup Buy
2019-11-07 재확인 Canaccord Genuity Buy
2019-11-07 업그레이드 Guggenheim Neutral → Buy
2019-10-23 개시 Stifel Buy
2018-11-28 개시 UBS Neutral
2018-10-19 업그레이드 Goldman Sell → Neutral
2018-09-12 업그레이드 Northland Capital Under Perform → Market Perform
2018-08-02 재확인 Canaccord Genuity Buy
2018-07-02 업그레이드 Raymond James Mkt Perform → Outperform
2018-06-08 업그레이드 JP Morgan Neutral → Overweight
2018-05-11 개시 BofA/Merrill Buy
2018-05-03 재확인 Canaccord Genuity Buy
2018-04-04 개시 Goldman Sell
2018-04-04 개시 Guggenheim Neutral
2018-03-23 업그레이드 Robert W. Baird Neutral → Outperform
2018-01-04 다운그레이드 Northland Capital Market Perform → Under Perform
2017-09-28 재확인 Wedbush Outperform
모두보기

덱스컴 주식(DXCM)의 최신 뉴스

pulisher
04:43 AM

What analysts say about DexCom Inc DC4 stockSector Performance Drivers & Diversify Intelligently to Avoid Big Hits - earlytimes.in

04:43 AM
pulisher
Oct 06, 2025

Applying big data sentiment scoring on DexCom Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can DexCom Inc. (DC4) stock deliver consistent EPS growthWeekly Trend Summary & Low Risk Entry Point Guides - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

DexCom May Be The Most Underrated Growth Story In Healthcare (NASDAQ:DXCM) - Seeking Alpha

Oct 06, 2025
pulisher
Oct 06, 2025

What dividend safety rating applies to DexCom Inc. (DC4) stockEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Combining price and volume data for DexCom Inc.July 2025 Fed Impact & Daily Growth Stock Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can DexCom Inc. stock deliver sustainable ROEM&A Rumor & Verified Swing Trading Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

DexCom, Inc. Reports Second Quarter 2017 Financial Results - ADVFN

Oct 05, 2025
pulisher
Oct 05, 2025

Is DexCom Inc. (DC4) stock resilient in recession scenariosPortfolio Risk Summary & Technical Pattern Alert System - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 05:15:42 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is DexCom Inc. stock entering bullish territoryWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can DexCom Inc. (DC4) stock sustain double digit ROE2025 Technical Overview & Low Volatility Stock Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Why Analysts See DexCom’s Outlook Shifting Amid New Leadership and Changing Growth Drivers - Yahoo Finance

Oct 04, 2025
pulisher
Oct 03, 2025

DexCom Stock Price, Quotes and Forecasts | NASDAQ:DXCM - Benzinga

Oct 03, 2025
pulisher
Oct 03, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc.DXCM - WV News

Oct 03, 2025
pulisher
Oct 03, 2025

What MACD trends signal for DexCom Inc. (DC4) stockBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to escape a deep drawdown in DexCom Inc.Quarterly Profit Report & AI Powered Market Entry Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time. - BioSpace

Oct 03, 2025
pulisher
Oct 02, 2025

Why DexCom Inc. stock remains on watchlistsBond Market & Real-Time Stock Movement Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

North America Precision Nutrition Market Analysis Report 2025-2032: Abbott, Dexcom, Nestle and DSM Lead Ecosystem Expansion with Integrated Diagnostics and Supplements - Yahoo Finance

Oct 02, 2025
pulisher
Oct 02, 2025

DexCom (NASDAQ:DXCM) Given New $89.00 Price Target at The Goldman Sachs Group - Defense World

Oct 02, 2025
pulisher
Oct 02, 2025

DexCom (NASDAQ:DXCM) Trading Down 4.9% on Analyst Downgrade - Defense World

Oct 02, 2025
pulisher
Oct 01, 2025

Goldman Sachs Maintains DexCom (DXCM) Buy Recommendation - Nasdaq

Oct 01, 2025
pulisher
Oct 01, 2025

TD Cowen Maintains its Buy Rating and $100 PT for DexCom, Inc. (DXCM) - Insider Monkey

Oct 01, 2025
pulisher
Oct 01, 2025

DEXCOM SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire

Oct 01, 2025
pulisher
Oct 01, 2025

DexCom, Inc. (DXCM) Showcases Next-Gen CGM Features at EASD 2025 - Insider Monkey

Oct 01, 2025
pulisher
Oct 01, 2025

Goldman Sachs Adjusts Price Target on DexCom to $89 From $104, Maintains Buy Rating - MarketScreener

Oct 01, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 04:25:09 - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

TD Private Client Wealth LLC Lowers Stock Holdings in DexCom, Inc. $DXCM - Defense World

Oct 01, 2025
pulisher
Sep 30, 2025

DexCom, Inc. $DXCM Shares Acquired by Farther Finance Advisors LLC - Defense World

Sep 30, 2025
pulisher
Sep 30, 2025

DexCom’s (DXCM) “Buy” Rating Reaffirmed at Canaccord Genuity Group - Defense World

Sep 30, 2025
pulisher
Sep 29, 2025

DexCom (DXCM) Maintains Buy Rating with Price Target Unchanged a - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

DexCom (NASDAQ:DXCM) Earns Buy Rating from Canaccord Genuity Group - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Will Rising Costs Hurt Garodia Chemicals Limiteds Margins This YearEarnings Per Share Trends & Free Long-Term Investment Planning - earlytimes.in

Sep 29, 2025

덱스컴 (DXCM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices PHG
$27.83
price down icon 0.75%
medical_devices STE
$241.56
price up icon 0.38%
$313.45
price up icon 0.56%
$74.49
price down icon 2.51%
medical_devices EW
$76.72
price up icon 0.21%
자본화:     |  볼륨(24시간):